Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Flavivirus non-structural protein 5 (NS5) N-terminal methyltransferase is a multifunctional enzyme essential for the viral life cycle, specifically responsible for the formation of the 5' RNA cap structure (UniProtKB - P03314). This domain exhibits N7-guanine methyltransferase and 2'-O-ribose methyltransferase activities, which sequentially modify the viral RNA to resemble host mRNA (Dong et al., 2014, Antiviral Res). These modifications are critical for ensuring efficient translation of the viral genome by the host machinery and for protecting the viral RNA from degradation by 5'-3' exonucleases (Bollati et al., 2010, FEBS Lett). Additionally, the 2'-O-methylation serves as a key mechanism for immune evasion, as it prevents the activation of host innate immune sensors like RIG-I and MDA5 that typically recognize unmethylated viral RNA (Züst et al., 2011, Nature). Given its high conservation across the Flaviviridae family—including Dengue, Zika, and West Nile viruses—and its distinct structural features compared to human methyltransferases, it is a high-priority target for broad-spectrum antiviral drug development (Lim et al., 2015, Antiviral Res). Current drug discovery efforts focus on S-adenosyl-L-methionine (SAM) competitive inhibitors and allosteric inhibitors that disrupt the enzyme's interaction with RNA or its internal conformational stability (Brecher et al., 2015, Chem Biol Drug Des). Small molecules like Sinefungin have demonstrated proof-of-concept inhibition, though selectivity remains a challenge (PubMed: 24931016). Successful targeting of this enzyme could lead to treatments that both reduce viral replication and restore the host's ability to detect the infection (PubMed: 25809195).
Competitive inhibition of the S-adenosyl-L-methionine (SAM) binding site or the RNA-binding groove to prevent N7 and 2'-O methylation of viral RNA (PubMed: 24931016).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flavivirus non-structural protein 5 N-terminal methyltransferase (NS5-MTase) (NS5-MTase).